Dr Reddy’s Launches Generic Semaglutide Injection
MM Desk
23 May, 2026
Dr Reddy’s Laboratories has announced the launch of its generic Semaglutide Injection in Canada, marking
Dr Reddy’s Laboratories has announced the launch of its generic Semaglutide Injection in Canada, marking
Aspect Biosystems, a biotechnology company developing advanced regenerative medicine solutions, has announced a $79 million
Biocon Biologics Ltd (BBL), a global biopharmaceutical company and subsidiary of Biocon Ltd has received
The recent tensions between India and Canada have sparked a significant controversy on the global